MedTrace Logo

Neopterin Dosage in the Eye

NCT03497481 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2022-10-26

No results posted yet for this study

Summary

The purpose of the study is to determine whether neopterin can be dosed in the fluid of the eye's anterior chamber for patient with non-inflammatory and non-infectious ophthalmic pathology.

Conditions

  • Cataract

Interventions

BIOLOGICAL

Samples

Eye's anterior chamber fluid and urines are sampled for posterior neopterin analysis

Sponsors & Collaborators

  • Hospices Civils de Lyon

    collaborator OTHER

  • Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer

    lead OTHER

Principal Investigators

  • Chaker Nefzaoui, doctor · Centre Hospitalier Intercommunal Toulon La Seyne sur Mer

  • Anélia Benarrosh, doctor · Centre Hospitalier Intercommunal Toulon La Seyne sur Mer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-22
Primary Completion
2019-01-25
Completion
2019-01-25

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03497481 on ClinicalTrials.gov